Aventis Inc.
Aventis Inc., a prominent player in the biotechnology and pharmaceutical industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in innovative drug development and biopharmaceutical solutions, with a strong operational presence across North America and Europe. Specialising in cutting-edge therapies for chronic diseases, Aventis Inc. is renowned for its unique approach to personalised medicine, which sets it apart from competitors. The company has achieved significant milestones, including the successful launch of several groundbreaking treatments that have transformed patient care. With a commitment to research and development, Aventis Inc. continues to enhance its market position, earning accolades for its contributions to healthcare and its dedication to improving patient outcomes.
DitchCarbon Score
How does Aventis Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aventis Inc.'s score of 100 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aventis Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Sanofi, from which it inherits climate commitments and initiatives. Aventis Inc. aligns its climate strategy with Sanofi's sustainability goals, which include participation in various initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 commitment to renewable energy. These initiatives reflect a commitment to reducing greenhouse gas emissions and transitioning to sustainable energy sources. While specific reduction targets for Aventis Inc. are not detailed, the overarching goals set by Sanofi provide a framework for emissions reduction and climate action. As a current subsidiary of Sanofi, Aventis Inc. benefits from the parent company's established climate strategies and performance metrics, which aim to enhance sustainability across its operations. In summary, while Aventis Inc. does not have specific emissions data or reduction targets available, it is committed to climate action through its association with Sanofi, leveraging inherited initiatives to drive sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aventis Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
